Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

NAUnknownINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

November 30, 2017

Conditions
Rheumatoid ArthritisJuvenile Idiopathic Arthritis
Interventions
PROCEDURE

Sampling of blood

Sampling of blood for dosage of antibodies

Trial Locations (1)

94275

CHU Bicêtre, Le Kremlin-Bicêtre

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

University College London (UCL) Cancer Institute

OTHER

collaborator

University of Florence

OTHER

collaborator

Pediatric Rheumatology International Trials Organization

OTHER

collaborator

Istituto Giannina Gaslini

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

University Hospital, Tours

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER